| Autor: |
Enos CW; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., Yi JZ; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., Ormaza Vera A; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia., McLean RR; CorEvitas, LLC, Waltham, Massachusetts., Sima AP; CorEvitas, LLC, Waltham, Massachusetts., Eckmann T; CorEvitas, LLC, Waltham, Massachusetts., Van Voorhees AS; Department of Dermatology, Eastern Virginia Medical School, Norfolk, Virginia. Electronic address: vanvooas@evms.edu. |
| Abstrakt: |
Competing Interests: Conflicts of interest Dr Enos has previously served as a consultant on an advisory board for UCB and Amgen, is an investigator for Amgen and Castle Biosciences, and has previously received research funding from the ASA/Arcutis Biotherapeutics. Authors McLean, Sima, and Eckmann are employed by CorEvitas, LLC. Dr Van Voorhees has received grant/research support from Celgene, Lilly, and AbbVie and is a consultant for Amgen, Boehringer Ingelheim, BMS, UCB, and Novartis. Dr Yi and Vera have no conflicts of interest to declare. |
Full Text from ScienceDirect